JBTM 8-K Filed 2026-08-03 New authorization

JBT Marel authorizes $200M share repurchase program

Board-authorized buyback through May 2029; company repurchased $26M of stock in Q2 2026

Authorization$179M
Remaining$174M
MechanismNot specified

What the filing says

JBT Marel Corporation's Board of Directors authorized a $200 million share repurchase program effective May 18, 2026, through May 31, 2029. The authorization permits the company to repurchase up to $200 million of its common stock over the three-year period.

During the second quarter of 2026, JBT Marel repurchased approximately 200,000 shares for $26 million under the program. The company did not disclose the average price paid per share or the execution mechanism in this filing.

The buyback authorization comes as JBT Marel reported solid operational performance, with second-quarter 2026 revenue of $981 million and adjusted EBITDA of $168 million. The company maintained a net debt-to-trailing-twelve-months adjusted EBITDA leverage ratio of 2.47x as of June 30, 2026, within its target range of 2.0x–2.5x. Management emphasized disciplined capital allocation while navigating integration of the JBT and Marel combination and operational improvements.

200000000
As previously announced, JBT Marel's Board of Directors authorized a share repurchase program for the purchase of up to $200 million of the Company's common stock, effective from May 18, 2026, through May 31, 2029. During the second quarter 2026, the Company repurchased approximately 200,000 shares of common stock for $26 million. — JBT MAREL Corp 8-K filing  ·  View on SEC EDGAR →

What this means

The $200 million authorization signals JBT Marel's confidence in capital structure and cash generation despite near-term operational headwinds from inflationary pressures and supply-chain optimization. With $26 million deployed in Q2 2026 (approximately 13% of the authorization), the company retains $174 million in buyback capacity. At a $130 average repurchase price, the Q2 execution reduces share count by roughly 0.4%, supporting per-share metrics. The three-year window (through May 2029) provides flexibility, allowing management to time repurchases opportunistically while maintaining leverage at 2.47x—comfortably within target—and funding organic growth and integration initiatives.

Frequently asked questions

What is the scope of JBT Marel's repurchase authorization?
JBT Marel's Board authorized a $200 million program effective May 18, 2026, through May 31, 2029. The company repurchased 200,000 shares for $26 million in Q2 2026, leaving approximately $174 million in remaining authorization capacity.
How does this buyback fit within JBT Marel's capital allocation strategy?
The repurchase program reflects management confidence in the company's integrated JBT Marel business and cash generation. The company prioritizes maintaining leverage within its 2.0x–2.5x target range while funding integration costs, operational improvements, and disciplined capital returns to shareholders.
What was the average price paid in Q2 2026?
The filing discloses that the company repurchased approximately 200,000 shares for $26 million in Q2 2026, implying an average repurchase price of approximately $130 per share.
How does the buyback relate to JBT Marel's current financial position?
As of June 30, 2026, JBT Marel reported net debt of $1.586 billion and a leverage ratio of 2.47x adjusted EBITDA—within target. The company generated $179 million in free cash flow year-to-date 2026, providing a foundation for disciplined buyback execution alongside debt management.
What execution mechanism did the company use?
The filing does not specify the execution mechanism (e.g., Rule 10b-18 open-market, 10b5-1 plan, accelerated share repurchase, or other method) for the Q2 2026 repurchases.
Will JBT Marel continue repurchasing under this authorization?
The authorization extends through May 31, 2029, but timing and pace depend on business conditions, market opportunities, leverage targets, and cash deployment priorities. Management has not provided a specific repurchase schedule or volume guidance for the remainder of 2026.
authorization mega-cap industrial 2026 q2-execution
Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.